教室紹介

2023年業績集

原著

  1. Matsuoka Y, Ueno Y, Uehara S, Tanaka H, Kobayashi M, Tanaka H, Yoshida S, Yokoyama M, Kumazawa I, Fujii Y. Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. Int J Urol. 30(12); 1103-1111, 2023. PubMed

  2. Chen W, Yokoyama M, Waseda Y, Kobayashi M, Fan B, Fukuda S, Tanaka H, Yoshida S, Ai M, Fushimi K, Fujii Y. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study. Int J Urol. 30(11); 1014-1019, 2023. PubMed

  3. Ohba K, Monji K, Osawa T, Yamana K, Yasuda Y, Tanaka H, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H, Sakai H, Eto M. Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. Int J Urol. 30(11); 977-984, 2023. PubMed

  4. Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study. Sci Rep. 13(1); 20629, 2023. PubMed

  5. Kataoka M, Yokoyama M, Waseda Y, Ito M, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Masuda H, Fujii Y. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Low Urin Tract Symptoms. 16(1); 12507, 2023. PubMed

  6. Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients.Clin Genitourin Cancer. 22(2); 193-200, 2023. PubMed

  7. Ishikawa Y, Tanaka H, Fujiwara M, Nakamura Y, Fukuda S, Waseda Y, Yoshida S, Yokoyama M, Fujii Y. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid. Int J Urol. 31(3); 238-244, 2023. PubMed

  8. Fan B, Yokoyama M, Kobayashi M, Nakamura Y, Fujiwara M, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. Int J Urol. 31(2); 119-124, 2023. PubMed

  9. Osawa T, Oya M, Okanishi T, Kuwatsuru R, Kawano H, Tomita Y, Niida Y, Nonomura N, Hatano T, Fujii Y, Mizuguchi M, Shinohara N. Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update. Int J Urol. 30(10); 808-817, 2023. PubMed

  10. Arita Y, Kwee TC, Woo S, Shigeta K, Ishii R, Okawara N, Edo H, Waseda Y, Vargas HA. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System. Eur Urol Focus. 10(1); 131-138, 2023. PubMed

  11. Yuan JH, Tanaka H, Patil D, Hakimi K, Soliman S, Meagher MF, Saidian A, Walia A, Dhanji S, Liu F, Afari J, Nguyen M, Wang L, Yasuda Y, Saito K, Fujii Y, Master V, Derweesh HI. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 21(4); e219-e227, 2023. PubMed

  12. Yoshida S, Takahara T, Tanaka H, Yokoyama M, Yoshimura R, Fujii Y.The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer Int J Urol. 30(7); 616-617, 2023. PubMed

  13. Soma T, Yoshida S, Wakejima R, Taguchi T, Fukuda S, Tanaka H, Yokoyama M, Ohashi K, Okubo K, Fujii Y. A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy. IJU Case Rep. 6(4); 216-218, 2023. PubMed

  14. Osawa T, Fujii Y, Kimura G, Kitamura H, Nagashima Y, Iizumi S, Osaka T, Tsubouchi R, Shinohara N. Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care). BMJ Open. 13(7); e070275, 2023. PubMed

  15. Yonese I, Ito M, Waseda Y, Kobayashi S, Toide M, Takazawa R, Koga F. Impact of diagnostic ureteral catheterization on intravesical tumour recurrence following radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 41(7); 1869-1875, 2023. PubMed

  16. Yamaguchi Y, Tanaka H, Kimura K, Fukuda S, Fukushima H, Waseda Y, Yoshida S, Yokoyama M, Hirakawa A, Tateishi U, Campbell SC, Fujii Y. Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. Int J Urol 30(10); 913-921, 2023. PubMed

  17. Ide H, Akehi Y, Fukuhara S, Ohira S, Ogawa S, Kataoka T, Kumagai H, Kobayashi K, Komiya A, Shigehara K, Syuto T, Soh J, Tanabe M, Taniguchi H, Chiba K, Matsushita K, Mitsui Y,Yoneyama T, Shirakawa T, Fujii Y, Kumano H, Ueshiba H, Amano T, Sasaki H, Maeda S, Mizokami A, Suzuki K, Horie S. Summary of the clinical practice manual for late-onset hypogonadism. Int J Urol. 30(5); 422-430, 2023. PubMed

  18. Kimura K, Yoshida S, Tsuchiya J, Kitazume Y, Waseda Y, Tanaka H, Yokoyama M, Toda K, Yoshimura R, Masaya I, Koga F, Tateishi U, Fujii Y. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. Eur Radiol. 33(9); 6245-6255, 2023. PubMed

  19. Tamiya T, Takazawa R, Uchida Y, Waseda Y, Kobayashi M, Fuse H. Stone-event-free survival after ureteroscopic lithotripsy by age: comparison between young and older patients. Urolithiasis. 51(1); 74, 2023. PubMed

  20. Uchida Y, Yokoyama M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujiwara T, Fujii Y. Preservation of erectile and ejaculatory functions after tetramodal bladder-sparing therapy incorporating consolidative partial cystectomy against muscle invasive bladder cancer. Urol Res Pract. 49(3); 162-168, 2023. PubMed

  21. Kijima T, Fukuda S, Fukushima H, Uehara S, Yasuda Y, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Fujii Y. The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma. Jpn J Clin Oncol. 53(5); 436-442, 2023. PubMed

  22. Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study. Int J Urol. 30(3); 258-263, 2023. PubMed

  23. Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Jpn J Clin Oncol. 53(3); 263-269, 2023. PubMed

  24. Hata C, Fukawa Y, Motoi T, Kinowaki Y, Akashi T, Ohashi K, Ishikawa Y, Waseda Y, Fujii Y, Kakuta R, Ikeda S, Onishi I. A Primary Kidney Giant Cell Tumor of Soft Tissue Caused Peritoneal Dissemination, Considered to Be Malignant Transformation: A Case Report. Diagnostics (Basel). 13(4); 752, 2023. PubMed

  25. Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-na¨ıve patients on survival in renal cell carcinoma. BJU Int. 131(2); 219-226, 2023. PubMed

  26. Kaneko H, Fujiwara M, Tanaka H, Kimura K, Yoshida S, Fujii Y. Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma Int J Urol. 30(11); 056-1058, 2023. PubMed

  27. Soma T, Fukuda S, Matsuyama Yusuke, Ikeda R, Inoue M, Waseda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujiwara T, Kageyama Y, Fujii Y. Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy. Int J Urol. 30(6); 532-538, 2023. PubMed

  28. Fujiwara M, Yoshida S, Takahara T, Soma T, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yokoyama M, Fujii Y. Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer. Clin Exp Metastasis. 40(2); 187-195, 2023. PubMed

  29. Yoshida S, Takahara T, Arita Y, Ito M, Hayakawa S, Oguchi T, Komai Y, Numao N, Yuasa T, Inoue M, Ushijima H, Kudo S, Shimano Y, Nakamura Y, Uchida Y, Uehara S, Tanaka H, Yaegashi H, Izumi K, Yokoyama M, Matsuoka Y, Yoshioka Y, Konishi K, Nakanishi K, Nagahara A, Hirakawa A, Koike R, Koga F, Nishimura K, Mizokami A, Yonese J, Kageyama Y, Yoshimura R, Fujii Y. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL). BMC Urol. 23(1); 33, 2023. PubMed

  30. Tanaka H, Fukuda S, Kimura K, Fukawa Y, Yamamoto K, Fukushima H, Moriyama S, Yasuda Y, Uehara S, Waseda Y, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Tateishi U, Campbell SC., Fujii Y. Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. Eur Urol Open Sci. 48; 36-43, 2023. PubMed

  31. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. Int J Urol. 30(2); 204-210, 2023. PubMed

  32. Mizuno Y, Yoshida S, Okamoto K, Fujii Y. Utility of an endoscopic image processing system for framing laparoscopic images using surgeon's gaze point and voice commands during laparoscopic percutaneous extraperitoneal closure of inguinal hernia in children. Videosurgery Miniinv. 18(2); 372-377, 2023. PubMed